Devices › Device types
FDA product code NHL · class 3 · Unknown
Stimulator, electrical, implanted, for parkinsonian symptoms: medical device reports filed with FDA
1,824 reports carry this product code, 2003–2026; 9 brands with a page.
- 1,824
- reports with this product code
- 0% of all MAUDE reports
- 169
- reports, 12 months to August 2026
- 228 in the 12 months before
- 9.9%
- classified as malfunction
- 62.3% across all reports
- 2.3%
- classified as death, as reported
- 0.9% across all reports
Product code NHL is FDA's classification for "Stimulator, electrical, implanted, for parkinsonian symptoms" (unknown panel), a class 3 device. 1,824 medical device reports carry this product code, 0% of the MAUDE database, from January 2003 to August 2026.
169 reports arrived in the 12 months to August 2026, down 26% from 228 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (87.7%), malfunction (9.9%) and death (2.3%). 9 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Vercise? Cartesia? | 706 | 132 | 2.4% | 2.5% |
| Vercise Genus | 580 | 338 | 2.4% | 17.2% |
| Vercise Gevia? | 143 | 26 | 2.3% | 2% |
| Vercise | 55 | 43 | 0.4% | 7.7% |
| Vercise Pc | 19 | 15 | 1.3% | 12.8% |
| SureTek? | 8 | 31 | 0% | 16.6% |
| Infinity 7 Implantable Pulse Generator | 4 | 147 | 0.5% | 2.5% |
| Infinity 5 Implantable Pulse Generator | 2 | 22 | 0.6% | 3.1% |
| Dbs | 1 | 0 | 2.9% | 23.8% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Boston Scientific Neuromodulation | 1,779 | 97.5% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Unexpected therapeutic results | 333 | 18.3% |
| High impedance | 151 | 8.3% |
| Migrationthe device moved from where it was placed | 136 | 7.5% |
| Charging problem | 80 | 4.4% |
| Battery problema problem with the battery | 62 | 3.4% |
| Wireless communication problema wireless connection problem | 62 | 3.4% |
| Inappropriate/inadequate shock/stimulation | 42 | 2.3% |
| Intermittent energy output | 35 | 1.9% |
| Fracturea broken bone | 30 | 1.6% |
| Premature discharge of battery | 30 | 1.6% |
| Inappropriate or unexpected reset | 20 | 1.1% |
| Off-label use | 16 | 0.9% |
| Defective devicethe device was defective | 15 | 0.8% |
| Delayed charge time | 11 | 0.6% |
| Overheating of device | 11 | 0.6% |
| Low impedance | 9 | 0.5% |
| Nonstandard device | 9 | 0.5% |
| Positioning problem | 8 | 0.4% |
| Device displays incorrect message | 6 | 0.3% |
| Unintended movement | 4 | 0.2% |
Questions about stimulator, electrical, implanted, for parkinsonian symptoms reports
What is product code NHL?
FDA's classification code for "Stimulator, electrical, implanted, for parkinsonian symptoms", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
1,824 reports through August 2026, 169 of them in the latest 12 months.
Which brands appear most often?
Vercise? Cartesia? (706), Vercise Genus (580), Vercise Gevia? (143), Vercise (55) and Vercise Pc (19). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.